Sponsor content
262 result(s) found, displaying 1 to 10
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 200 mg / 2 mL solution for injection, pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 200 mg / 2 mL solution for injection, pre-filled pen (auto-injector).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TREMFYA guselkumab 200 mg / 20 mL concentrated solution for intravenous infusion, vial.
-
Australian Public Assessment Report (AusPAR)Opsynvi (macitentan/tadalafil) is approved for maintenance treatment of pulmonary arterial hypertension in adult patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAZCLUZE lazertinib 240 mg film-coated tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAZCLUZE lazertinib 240 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAZCLUZE lazertinib 80 mg film-coated tablets bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for LAZCLUZE lazertinib 80 mg film-coated tablets blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DARZALEX daratumumab 100 mg/5 mL concentrated solution for infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for DARZALEX daratumumab 400 mg/20 mL concentrated solution for infusion vial.